AbCellera Biologics(ABCL) - 2025 Q3 - Quarterly Results

NEWS RELEASE AbCellera Reports Q3 2025 Business Results 11/6/2025 VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "AbCellera successfully delivered on two corporate priorities this quarter by starting activities at our new clinical manufacturing facility and substantially completing our platform investments," said Ca ...